In vitro model for studying malignancy associated changes

Analytical Cellular Pathology

Volumn 25, Issue 2, 2003, Pages 95-102

  Sun, Xiao Rong ^a,b   Zheng, Yonghong ^a   MacAulay, Calum ^a   Lam, Stephen ^a   Doudkine, Alexei ^a   Palcic, Branko ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell co culture; Image cytometry; Malignancy associated changes; Nuclear features

Indexed keywords

ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE CYTOMETRY; IN VITRO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MODEL; PRIORITY JOURNAL;

EID: 0037262158     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/238921     Document Type: Article

References (25)

1. M. Bibbo, F. Michelassi, P.H. Bartels, C. Bania, E. Lerma and A.G. Montag. Karyometric marker features in normal-appearing glands adjacent to human colonic adenocarcinoma, Cancer Res. 50 (1990), 147-167.
2. A. Bocking, S. Biesterfeld, R. Chatelain, G. Gien-Gerlach and E. Esser, Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum: sensitivity and specificity of an alternative to routine cytology, Acta Cytol. 36(1) (1992), 37-47.
3. M. Brower, D.N. Carney, H.K. Oie, A. Gazda and J.D. Minna, Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium, Cancer Res. 46 (1986), 798-806.
4. G. Burger, U. Jutting and K. Rodinacker, Changes in the benign cell population in cases of cervical cancer and its precursors, Analyt. Quant. Cytol. 3 (1981), 261-271.
5. D.N. Carney, The biology of lung cancer, Curr. Opin. Oncol. 4(2) (1992), 292-298.
6. A. Doudkine, C. MacAulay, B. Poulin and B. Palcic, Nuclear texture measurements in image cytometry, Pathologica 87 (1995), 286-299.
7. R.R. Finch, A classification of nuclear aberration in relation to malignancy associated changes (MAC), Acta Cytol. 15 (1971), 553-558.
8. R.R. Finch and E. von Haam, Malignancy associated changes in buccal smears, Acta Cytol. 15 (1971), 46-49.
9. G. Giaccone, J. Battey, A.F. Gazdar, H. Oie, M. Draoui and T.W. Moody, Neuromedin B is present in lung cancer cell lines, Cancer Res. (Suppl.) 52 (1992), 2732s-2736s.
10. O.C. Gruner, Study of the changes met with the leukocytes in certain cases of malignant disease, Br. J. Surg. 3 (1916), 505-522.
11. M. Guillaud, A. Doudkine, D. Garner, C. MacAulay and B. Palcic, Malignancy associated changes in cervical smears: systemic changes in cytometric features with the grade of dysplasia, Analyt. Cell. Pathol. 9 (1995), 191-204.
12. K. Kelly, M.A. Kane and P.A. Bunn, Jr., Growth factors in lung cancer: possible etiologic role and clinical target, Med. Pediat. Oncol. 19(6) (1991), 450-458.
13. H. Klawe and J. Rowinski, Malignancy associated changes (MAC) in cells of buccal smears detected by objective image analysis, Acta Cytol. 18 (1974), 30-33.
14. C. MacAulay, S. Lam, P. Payne, J. leRiche and B. Palcic, Malignancy-associated changes in bronchial epithelial cells in biopsy specimens, Analyt. Quant. Cytol. Histol. 17 (1995), 55-61.
15. C. MacAulay, S. Lam, P. Payne and B. Palcic, Malignancty associated changes in epithelial cells from bronchial biopsies, Chest 103 (1993), 260S.
16. A.G. Montag, P.H. Bartels, J.E. Dytch, E. Lerma-Puertas, F. Micholassi and M. Bibbo, Karyometric features in nuclei near colonic adenocarcinomas: Statistical analysis, Analyt. Quant. Cytol. Histol. 13 (1991), 159-167.
17. H.E. Nieburgs, A.F. Goldberg, B. Bertini, J. Silagi, B. Pacheco and H. Reisman, Malignancy associated changes (MAC) in blood and bone marrow cells of patients with malignant tumors, Acta Cytol. 11(5) (1967), 415-423.
18. H.E. Nieburgs, A.D. Parets, V. Perez and C. Boudreau, Cellular changes in liver tissue adjacent and distant to malignant tumors, Arch. Pathol. (1965), 80.
19. H.E. Nieburgs, Recent progress in the interpretation of malignancy associated changes (MAC), Acta Cytol. 12(6) (1968), 445-453.
20. H.E. Nieburgs, R.G. Zak, D.C. Allen, H. Reisman and T. Clandy, Systemic cellular changes in material from human and animal tissues in presence of tumours, in: Transactions of the Seventh Annual Meeting of the International Society of Cytology Council, 1959, pp. 137.
21. B. Palcic and C. MacAulay, Malignancy associated changes. Can they be employed clinically?, in: Compendium on Computerized Cytology and Histology Laboratory, G.L. Wied and D.L. Rosenthal, eds, Tutorial of Cytology, Chicago, IL, USA, 1994, pp. 157-165.
22. B. Palcic, Nuclear texture: can it be used as a surrogate endpoint biomarker?, J. Cell. Biochem. 19 (1994), 40-46.
23. P. Payne, T.J. Sebo, A. Doudkine, D. Garner, C. MacAulay, S. Lam, J.C. leRiche and B. Palcic, Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study, Mayo Clin. Proc. 72(8) (1997), 697-704.
24. A. Tezcan, D.M. Garner, P. Lam, J. Korbelik and B. Palcic, Analysis of thionin, gallocyanin and hematoxylin for automated quantitative image cytometry of cervical samples, in: 8th Annual Meeting, Clinical Applications of Cytometry, South Carolina, September 1993, pp. 15-18.
25. G.L. Wied, P.H. Bartels, M. Bibbo and J.J. Suchra, Cytomorphometric markers for uterine cancer in intermediate cells, Analyt. Quant. Cytol. 2 (1980), 257-263.